Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2005
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964785 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same
11/15/2005US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
11/15/2005US6964780 Phosphodiesterase inhibitor; therapy for sexual disorders; sildenafil in polyoxyethylene glycol enteric coating
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
11/10/2005WO2005106459A1 Method of determining ability of drug to bind to troponin i and test drug for the determination
11/10/2005WO2005105826A1 Tyropeptin a analogue
11/10/2005WO2005105793A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105722A1 Crystal comprising (2r)-2-propyloctoic acid and amine
11/10/2005WO2005105156A1 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105127A1 Citrus fruit skin extract for angiogenesis promotion
11/10/2005WO2005002672A3 Sirt1 modulators for manipulating cells/organism lifespan/stress response
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005WO2001009093A8 Benzenamine derivatives as anti-coagulants
11/10/2005US20050250850 Amino acid composition promoting collagen synthesis
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250845 Pseudopolymorphic forms of a hiv protease inhibitor
11/10/2005US20050250843 synergistic antihypoxic mixture: acetylcholine esterase inhibitor (Donepezil and Tacrine) and neuroprotectant 1-[3-(2-(1-benzothiophen-5-yl)ethoxy)propyl]-3-azetidinol maleate; dysfunction of cerebral acetylcholine neurons in sequelae of cerebrovascular and senile dementia, Alzheimer's disease
11/10/2005US20050250834 11-(Aminoalkyl)isoindolo[2,1-a]indol-6-ones: 11-(2-Dimethylaminoethyl)-2-fluoroisoindolo[2,1-a]indol-6-one; psychological disorders, drug abuse, sleep disorders, Alzheimer's, Parkinson's and Huntington's disease, Irritable bowel syndrome, chemotherapy induced emesis, spinal trauma and/or head injury
11/10/2005US20050250832 For increasing blood-brain barrier permeability
11/10/2005US20050250827 Preparation of candesartan cilexetil in high purity
11/10/2005US20050250825 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250802 Novel substituted amines of spirofuropyridines useful in therapy
11/10/2005US20050250796 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
11/10/2005US20050250793 Preventives/remedies for hot flash
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250777 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250727 Use of immunomodulating agents
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250715 Remedy
11/10/2005US20050250710 Antiaging composition
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050250693 Metalloproteinase inhibitors
11/10/2005US20050250672 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents
11/10/2005US20050250671 Activators of peroxisome proliferator-activated receptor
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050250166 Cdc7-ask kinase complex, substrates of the kinase complex, antibody specific to the substrate, and method of screening compound capable of inhibiting cdc7-ask kinase using the same
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050249796 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
11/10/2005US20050249783 Method of improving absorption of vitamin e by a pet animal
11/10/2005US20050249761 Topical composition comprising at least one aryl oxime and bisabolol
11/10/2005US20050249738 Immunotoxins directed against malignant cells
11/10/2005US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249715 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
11/10/2005US20050249714 Method of using secretin and compositions made therefrom for the treatment of autism and other neurological, behavioral and immunological disorders
11/10/2005US20050249710 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005US20050247312 Medicament dispenser
11/10/2005DE10262005B4 Lebens-, Genuss-, Süßungs- und Arzneimittel, sowie Zusammensetzungen enthaltend kondensierte Palatinose in hydrierter Form Food, beverages, sweeteners and pharmaceuticals, as well as compositions containing condensed palatinose in hydrogenated form
11/10/2005DE10112926B4 Verwendung von Aminooxyacetat zur Tumorbehandlung Use of aminooxyacetate for tumor treatment
11/10/2005CA2565410A1 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
11/10/2005CA2565024A1 Therapeutic agent for left ventricular diastolic dysfunction
11/10/2005CA2564288A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidin-2-yl and 5, 6, 7, 8-tetrahydro-quinazolin-2-yl compounds
11/09/2005EP1593682A2 Derivatives of 4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides, process for their preparation and pharmaceutical compositions thereof
11/09/2005EP1593681A1 Tricyclic compound, process for producing the same, and use
11/09/2005EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593394A2 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
11/09/2005EP1593387A1 Compositions for the treatment of impaired interpersonal and behavioral disorders
11/09/2005EP1593380A2 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
11/09/2005EP1592670A1 Mercaptoimidazoles as ccr2 receptor antagonists
11/09/2005EP1592421A1 Heteroarylalkanoic acids as integrin receptor antagonists
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1423378B1 Aminopyrrole compounds as antiinflammatory agents
11/09/2005EP1419163B9 Tricyclic imidazopyridines
11/09/2005EP1411935A4 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1390369B1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives
11/09/2005EP1368025B1 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
11/09/2005EP1365748B1 Particulate composition of eletriptan hydrobromide showing a sigmoidal pattern of controlled release
11/09/2005EP1315714B1 Quinazoline derivatives as alpha-1 adrenergic antagonists
11/09/2005EP1309349B1 Pharmaceutical composition and method for the treatment of retroviral infections
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1196403B1 Antipsychotic cyclic n-aralkyl amines
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 1564